Affiliate disclosure: The RX Index earns a commission when you sign up with some of the providers mentioned on this page. It does not affect what you pay, and it never determines our rankings or which providers we cover. Read the full disclosure.

· Sources: CMS, KFF, Medicare.gov

Medicare GLP-1 Bridge Out-of-Pocket Maximum: Does the $50 Count?

Disclosure: Some links on this page are affiliate links. If you purchase through these links, we may earn a commission at no extra cost to you.

We are not affiliated with CMS, Medicare, Humana, Novo Nordisk, or Eli Lilly. Some links on this page may earn us a commission, at no extra cost to you. Every cost, date, and coverage rule comes from CMS, Medicare.gov, KFF, or the FDA — and we link our sources.

No. The $50 Medicare GLP-1 Bridge copay does not count toward your Part D out-of-pocket maximum. It also doesn’t count toward your deductible, and Extra Help won’t lower it.

The Bridge runs outside your normal Part D drug benefit — it’s a separate program with its own $50 price tag. So if you’re searching whether the $50 helps you hit your $2,100 cap faster — it doesn’t. But that’s not all bad news. And for some people, the Bridge isn’t even the smartest path.

QuestionAnswer
Does the $50 Bridge copay count toward my $2,100 Part D cap?No
Does it count toward my Part D deductible?No
Does Extra Help lower the $50?No
Is the Bridge still "Medicare"?Yes — but outside the normal Part D payment flow
When does it run?July 1, 2026 – December 31, 2027
What do I pay?$50 per monthly supply — the same in every benefit phase
Not sure which path you're even on — Bridge, standard Part D, or a cash-pay backup?

Free 60-second "Find My GLP-1 Path" quiz — plain-English answer before you talk to your prescriber.

Medicare GLP-1 Bridge out-of-pocket maximum: does the $50 count?

No. The $50 Medicare GLP-1 Bridge copay does not count toward your Part D out-of-pocket maximum, which is $2,100 in 2026. CMS confirms the Bridge operates outside the Part D benefit payment flow, so neither your $50 copay nor the drug’s cost is added to your true out-of-pocket (TrOOP) total — the running tally Medicare keeps of what you’ve spent on covered drugs.

Your Bridge spending and your regular Part D spending sit in two separate buckets that never touch. Let’s slow down on what “doesn’t count” really means, because this is the catch that trips people up.

It does not move you toward your $2,100 cap

Your Part D plan tracks how much you spend on covered drugs each year. Once you hit $2,100 in 2026, your covered drugs cost $0 for the rest of the year. The Bridge $50 does nothing to get you there.

It does not count toward your deductible either

The 2026 standard Part D deductible is $615. The $50 you pay for a Bridge drug won't chip away at that $615.

It doesn't shrink even after you hit your cap

Say you've already spent $2,100 on your other drugs and those are now free. You'll still pay $50 a month for your Bridge GLP-1. The $50 never drops to $0.

The Bridge lowers the price of the drug. It does not lower your Part D out-of-pocket journey.

Why did CMS build it this way? Standard Medicare Part D generally cannot cover medications when they’re used only for weight loss. So instead of forcing it into Part D, CMS created a separate short-term program — a “bridge” — that runs alongside Part D with its own rules. Your Part D plan doesn’t pay for it, doesn’t take on the financial risk, and doesn’t count your Bridge spending toward your Part D totals. A central processor (run by Humana on behalf of CMS) handles it separately.

Your 4 Medicare GLP-1 cost paths — and which dollars count toward your cap

Nobody else lays this out in one place. Here’s every path on one screen:

PathWhen it appliesWhat you payCounts toward $2,100 cap?Extra Help applies?
1. Medicare GLP-1 BridgeGLP-1 for weight loss, you qualify, you have Part D$50/mo flat❌ No❌ No
2. Standard Part DGLP-1 for a covered condition (diabetes, heart-risk, sleep apnea)Your plan’s copay, until you hit $2,100 then $0✅ Yes✅ Yes
3. Cash-pay (FDA-approved)Don’t qualify, can’t wait, or want an option the Bridge skipsRoughly $149–$699/mo❌ No❌ No
4. Compounded GLP-1A separate cash-pay lane — not a Medicare pathVaries by provider❌ No❌ No
Bottom line: Only Path 2 (standard Part D) spending counts toward your $2,100 cap. The Bridge ($50) and any cash-pay option sit completely outside it.

The real math: what the $50 Bridge actually costs you

At $50 a month, the Bridge costs about $300 for the second half of 2026 (July–December) and about $600 for all of 2027 — roughly $900 across the full program window. None of that counts toward your Part D out-of-pocket maximum.
PeriodMonthly copayMonthsBridge totalCounts toward cap?
July–Dec 2026$506$300❌ No
Jan–Dec 2027 (cap $2,400)$5012$600❌ No
Full Bridge window$5018$900❌ No

The Carol example — the math that actually matters

Carol spends about $2,100 a year out of pocket on her other Part D drugs — so she hits her cap, and those drugs go to $0. She also wants Wegovy for weight loss, through the Bridge.

Her total: $2,100 (capped) + $600 for the Bridge = $2,700. The two buckets never merge. The Bridge $600 doesn’t disappear when she hits her cap, and it doesn’t push her toward the cap. It’s a separate line in her budget. But for an eligible Medicare member paying cash today, a flat $50 is far below any current cash-pay price.

Run your own numbers — free cost path estimator

Answer three quick questions — your reason for the GLP-1, your other drug spending, and whether you’ll use the Bridge — and see your estimated yearly cost, which dollars count toward your $2,100 cap, and your likely best move.

Loading estimator…

If the estimator doesn’t load: Your Bridge cost = $50 × the number of months left in the program, and $0 of that counts toward your Part D deductible, your TrOOP, or your $2,100 cap. Your other covered Part D drugs are what move you toward the cap.

See your real cost before you commit to anything

Run the estimator above, then take the 60-second quiz for a step-by-step plan.

Bridge vs. standard Part D: which path should your GLP-1 use?

Use the Bridge when your GLP-1 is for weight loss and you qualify. Use standard Part D when the same drug is prescribed for a condition Medicare already covers — like type 2 diabetes, heart-risk reduction, or sleep apnea. CMS says those covered uses should go through your Part D plan, not the Bridge — and that spending does count toward your $2,100 cap.

The Bridge has one real weakness: that $50 never counts toward your $2,100 cap, and Extra Help can’t lower it. If reaching your cap faster is your top priority, and your drug qualifies under standard Part D, that path is better for you — check it first.

The question isn’t “is the Bridge good or bad?” It’s “what is my prescription actually for?” Same drug, different reason, completely different rules.

Your situationLook here firstWhy
Wegovy for weight loss onlyBridge$50/mo if approved; standard Part D won't cover weight-loss-only use
Wegovy for heart-risk reduction (established heart disease + obesity)Standard Part DCMS says this should not route to the Bridge — counts toward your cap
Zepbound for moderate-to-severe sleep apnea with obesityStandard Part DSleep apnea use can be Part D-covered (depends on your plan)
Ozempic, Mounjaro, or Rybelsus for type 2 diabetesStandard Part DThese are diabetes drugs, not Bridge weight-loss products
Foundayo for weight lossBridgeCMS includes Foundayo on the Bridge drug list
You don't qualify and have no covered conditionCash-pay backupThe Medicare path may not be open to you

If you think you belong on the standard Part D side, start with our guide on whether Medicare covers Zepbound and our full Bridge eligibility breakdown. Don’t default to the Bridge just because $50 sounds good — it may not be your cheapest option.

Does one of those rows sound like you?

Confirm your path with the quiz before anyone submits a prior authorization — a request sent to the wrong place can mean a denial.

Does Extra Help lower the $50 Bridge copay?

No. CMS says low-income cost-sharing subsidies — known as Extra Help, or the Low-Income Subsidy (LIS) — do not apply to the Bridge copay. If you normally pay only $5.10 for generics or $12.65 for brand-name covered Part D drugs because of Extra Help, do not assume your Bridge GLP-1 will drop to that amount. It stays at $50.

KFF has raised the same concern — that not being able to use Extra Help in the Bridge may put the $50 out of reach for some lower-income beneficiaries.

RouteTypical 2026 costExtra Help applies?Counts toward $2,100 cap?
Bridge GLP-1$50 / month, flat❌ No❌ No
Standard Part D — genericUp to $5.10 per drug✅ Yes✅ Yes
Standard Part D — brand-nameUp to $12.65 per drug✅ Yes✅ Yes
Standard Part D — after cap$0Already at cap

Extra Help amounts per Medicare.gov. Standard Part D coverage of a GLP-1 still depends on your plan’s formulary and prior-authorization rules.

Have Extra Help and not sure which way to go?

Use the quiz to compare your two paths — it could save you real money.

Will my coupon or savings card work? And what if the pharmacy bills it wrong?

No — CMS says manufacturer coupons and discount cards cannot be applied to Medicare GLP-1 Bridge claims, and the Bridge does not coordinate with other payers. Bridge claims must run through a central processor using a specific pharmacy billing code, not your regular Part D plan or a cash discount card.

The Bridge is run through a central processor

CMS selected Humana, the administrator of the federal LI NET program, to oversee prior authorizations, claims, and pharmacy payments. On the technical side, the official CMS pharmacy payer sheet lists SS&C Health as the claims processor, with claims routed through RelayHealth.

Pharmacies bill it with a special code: BIN 028918 / PCN MEDDGLP1BR

That's straight from the CMS payer sheet. If your pharmacist accidentally routes the claim to your normal Part D plan or a discount card, you can get the wrong price — or a denial.

Don't pay cash hoping to get reimbursed later

CMS says claims are processed electronically and paper claims won't be accepted.

Quick script for the pharmacy counter:

“Can you confirm this is being billed through the Medicare GLP-1 Bridge — BIN 028918, PCN MEDDGLP1BR — and not my regular Part D plan or a discount card?”

For the full step-by-step — what your doctor submits, the prior-authorization attestation, and what to bring — see our Medicare GLP-1 Bridge application process guide. We also cover the pharmacy routing codes in detail in our $50 copay guide.

When the $50 Bridge is NOT your best deal

The Bridge isn’t automatically the smartest path for everyone. Standard Part D can beat it when your GLP-1 treats a covered condition, when Extra Help lowers your copay, or when your other drugs are already pushing you toward the $2,100 cap.

You take Wegovy for heart-risk reduction

If you have established heart disease and are overweight or obese, Wegovy's heart-risk use can be covered under standard Part D — and CMS specifically says that use should not go through the Bridge. That spending counts toward your cap. The Bridge spending wouldn't.

You take Zepbound for sleep apnea

The FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity. If that's your situation, standard Part D may cover it — and that counts toward your cap.

You have type 2 diabetes

Ozempic, Mounjaro, and Rybelsus are diabetes drugs, not Bridge weight-loss products. Your Part D plan may cover them (with prior authorization), and those dollars count.

You have Extra Help

The Bridge ignores Extra Help. If your standard Part D copays are tiny because of it, the Bridge could actually cost you more.

You take several expensive Part D drugs

Bridge copays don't help you reach your cap. If your non-GLP-1 medications are pricey, your smartest route depends on your whole drug list — not just the GLP-1 price.

If any of these is you, start with the path check

The quiz points you to standard Part D, the Bridge, or a backup — based on your actual situation.

Who the $50 Bridge is genuinely best for

The Bridge is most valuable for a Medicare Part D member who needs a Bridge-listed GLP-1 for weight loss, meets the clinical criteria, has no cleaner covered-condition route, and would otherwise pay hundreds of dollars a month out of pocket. For that person, a flat $50 for an FDA-approved GLP-1 is the best Medicare deal available right now.

You’re likely a great fit if all of these are true:

  • You have Medicare Part D (a standalone drug plan or a Medicare Advantage plan with drug coverage).

  • You want a GLP-1 for weight loss, and you meet the BMI and health-condition criteria.

  • You don't have a separate covered condition (like diabetes or heart disease) that would route the same drug through standard Part D.

  • You can handle $50 a month — even though Extra Help won't lower it.

  • You understand the program is currently scheduled to end December 31, 2027 unless CMS extends it.

If that’s you, the next move is simple: confirm you’re enrolled in Part D, then talk to your prescriber about whether you meet the criteria so they can start the prior-authorization request.

Get the free Doctor Visit Cheat Sheet →

One page with the eligibility tiers, the exact wording your doctor needs, and the BIN/PCN — so nothing gets sent to the wrong place.

Which GLP-1 drugs are in the Medicare GLP-1 Bridge?

The Bridge currently covers Foundayo (orforglipron), all Wegovy formulations (the pen and the tablet), and the Zepbound KwikPen — when used for weight loss. CMS can update this list during the program. It does not cover diabetes-only GLP-1s or compounded versions.

✅ Covered through the Bridge

  • Foundayo (orforglipron) — the FDA-approved weight-loss pill
  • Wegovy — injection and tablet
  • Zepbound — the KwikPen specifically (not the vials or single-dose pens)

❌ Not covered through the Bridge

  • Ozempic, Mounjaro, Rybelsus (possible under standard Part D for diabetes, not the Bridge)
  • Other Zepbound formulations (vials, single-dose pens)
  • Compounded semaglutide or tirzepatide
Compounded GLP-1s are not the same as the FDA-approved drugs in the Bridge — and they are not a Medicare Bridge option. Compounded medications are custom-mixed by a pharmacy and are a cash-pay lane only. The two are separate when comparing costs.

Bridge drug list current as of May 28, 2026. CMS may add or change products and their drug codes during the program. Have your prescriber confirm against the current CMS list.

What happens after December 31, 2027?

CMS says the Medicare GLP-1 Bridge runs July 1, 2026 through December 31, 2027. It was originally meant to be a short six-month program, but CMS extended it after the longer-term BALANCE Model failed to get enough Part D plans to sign on. There is no guaranteed permanent replacement yet.
WhenWhat’s happening
July 1, 2026The Bridge starts
December 31, 2027The Bridge is currently scheduled to end
2027Part D out-of-pocket cap is reported at $2,400
2028 and beyondNo guaranteed Medicare Part D weight-loss-drug pathway unless CMS launches or replaces the BALANCE Model

Don’t assume “Medicare now covers weight-loss drugs forever” — it doesn’t, at least not yet. Re-check your coverage before the 2027 open enrollment, and again before the Bridge ends. For the full story on the long-term program and why it stalled, see our guide on what happened to the BALANCE Model.

What we actually verified

ClaimSourceVerified
Bridge runs July 1, 2026 – Dec 31, 2027CMS; KFFMay 28, 2026
$50 copay does not count toward TrOOP / $2,100 capCMS Bridge FAQ; KFF; NPRMay 28, 2026
Bridge operates outside the Part D payment flowCMS Bridge FAQMay 28, 2026
2026 Part D out-of-pocket max $2,100; deductible $615CMS; Medicare.govMay 28, 2026
Extra Help / LIS does not reduce the $50CMS Bridge FAQ; KFFMay 28, 2026
2026 full Extra Help copays: up to $5.10 generic / $12.65 brandMedicare.govMay 28, 2026
Coupons/discount cards can't be appliedCMS Bridge FAQMay 28, 2026
Covered drugs: Foundayo, Wegovy, Zepbound KwikPenCMS Bridge FAQ; KFFMay 28, 2026
Central processor Humana; SS&C Health/RelayHealth; BIN 028918 / PCN MEDDGLP1BRCMS payer sheet; CMS FAQMay 28, 2026
2027 cap reported at $2,400KFFMay 28, 2026

A note on reviews: As of May 28, 2026, the Bridge had not opened yet — it starts July 1, 2026. That means any “patient testimonial” about actually using the Bridge can’t be based on real, completed use. We’ll add genuine, permissioned reader experiences here after launch, only if we can verify them.

Frequently asked questions

Does the Medicare GLP-1 Bridge count toward my Part D out-of-pocket maximum?

No. The $50 Bridge copay does not count toward your Part D true out-of-pocket (TrOOP) total, and the drug's cost does not count toward your covered-drug spending. The Bridge runs outside your Part D plan.

Does the Bridge count toward my Part D deductible?

No. Because Bridge claims run outside the normal Part D payment flow, the $50 does not reduce your 2026 deductible of $615.

What is the 2026 Medicare Part D out-of-pocket maximum?

It is $2,100 for covered Part D drugs in 2026. Once you reach it, your covered Part D drugs cost $0 for the rest of the year. Bridge spending does not count toward this.

Does Extra Help reduce the $50 Bridge copay?

No. CMS says low-income subsidies do not apply to the Bridge. You will owe the full $50 even if your other Part D drugs cost you only a few dollars each.

Does the Medicare Prescription Payment Plan spread out the $50 Bridge copay?

No, do not assume it does. The Medicare Prescription Payment Plan lets you pay covered Part D drug costs in monthly amounts across the year. CMS says the Bridge runs outside the normal Part D payment flow, so plan for the $50 as its own separate monthly payment unless CMS releases Bridge-specific guidance.

Can I use a manufacturer coupon with the Bridge?

No. CMS does not allow coupons or discount cards on Bridge claims.

Is the Bridge better than standard Part D?

Sometimes. For weight-loss-only use, the Bridge is usually the cheapest path if you qualify. But if your drug is prescribed for a covered condition such as diabetes, heart-risk reduction, or sleep apnea, standard Part D may be cheaper and it counts toward your cap.

Does the Bridge cover Ozempic or Mounjaro?

Not as weight-loss Bridge drugs. Ozempic and Mounjaro may be covered through standard Part D for type 2 diabetes, depending on your plan and prior authorization.

Does the Bridge cover Zepbound vials?

No. The Bridge covers the Zepbound KwikPen, not the vials or single-dose pens.

What if I already hit my Part D out-of-pocket cap?

You still pay $50 a month for your Bridge GLP-1. The $50 stays the same no matter which phase of your Part D benefit you are in.

What happens after December 31, 2027?

The Bridge is set to end. The longer-term BALANCE Model is delayed and not guaranteed in every plan, so re-check your coverage before then.

The right answer depends on your reason for the GLP-1, your Part D plan, your Extra Help status, your full drug list, and whether you meet the Bridge criteria. The safest next step is to know your path before you ask your prescriber to send a request.

Take the free 60-second “Find My GLP-1 Path” quiz →

We’ll sort your likely route — Medicare GLP-1 Bridge, standard Part D, or a cash-pay backup — and give you a one-page plan to bring to your appointment.

What if the Bridge isn’t open to you, or you can’t wait until July 1?

If you don’t meet the criteria, don’t have a covered condition, or genuinely can’t wait, your remaining route is cash-pay outside Medicare. To be clear: if you qualify for the Bridge, $50/month beats every cash option — wait for it. This part is only for people the Bridge truly doesn’t serve.

One important heads-up for Medicare members: cash-pay GLP-1 programs set their own rules, and some don’t serve people with government coverage at all. The smart next step is checking eligibility first, before you enter any billing information.

Compare FDA-approved cash-pay GLP-1 options →

Shows which programs spell out their Medicare / government-coverage rules, so you only start somewhere that will actually take you.

Sources

  1. CMS — Medicare GLP-1 Bridge
  2. CMS — Medicare GLP-1 Bridge payer sheet (BIN/PCN)
  3. Medicare.gov — Part D costs and Help with drug costs (Extra Help)
  4. KFF — BALANCE Model and the Medicare GLP-1 Bridge
  5. NPR — Medicare's $50 GLP-1 option (May 6, 2026)
  6. FDA — Zepbound approval for obstructive sleep apnea

This guide is for general information and is not medical, legal, or financial advice. Medicare rules can change — always confirm details on Medicare.gov and with your own plan. By The RX Index Editorial Team. . We re-verify this page whenever CMS changes the Bridge drug list, copay rules, cap interaction, prior-authorization process, or end date.